At present, the European Liver Association and the American Association for the Study of Liver Diseases no longer recommend the determination of AFP levels for the diagnosis of liver cancer, and there are some doubts regarding the diagnostic sensitivity of AFP (Kim et al., 2016). This evidence concerns the gene AFP and liver cancer.